Junior Brand Associate
About the job
- Previous experience in a similar position; corporate experience is preferred.
- Experience with new ways of working.
- Social competence, communication skills, and openness to cross-functional teamwork.
- Proactive and solution-focused approach, self-confidence, a strong sense of responsibility, and prioritization skills.
- Ability to process and present complex topics clearly and in a structured way.
- Digital fluency and advanced project management skills.
- Ability to develop written and digital materials for audiences with different levels of understanding.
- Knowledge of information and communications technology, especially digital marketing channels.
- Computer skills, including developing graphics for presentation materials.
- Extended Microsoft Office knowledge, including presentation skills.
- A Master's degree in Marketing or another relevant field.
- Fluent English and very good German (at least B2).
- Coordinate and provide administrative support for projects accompanying ongoing changes.
- Support brand planning with the brand manager for established and new brands, including RSV, and prepare and implement operational marketing activities.
- Prepare performance analyses to support impact.
- Prepare marketing materials and campaigns, coordinating with Regulatory, Legal, Purchasing, Communication, Event Management, and agencies.
- Contribute to Sales meetings.
- Contribute to brand planning at the German level and in interaction with global teams.
- Conduct market analysis in coordination with the analytics department.
- Analyze the impact of marketing activities.
- Monitor performance against key indicators.
- Previous Pharma or Healthcare industry experience.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave